logo-loader

MGC Pharmaceuticals moves forward on collaborative process with partner AMC Holdings

Last updated: 10:27 06 Oct 2021 EDT, First published: 00:27 06 Oct 2021 EDT

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC)'s (ASX:MXC) Ron Lipsky, VP of Business Development & International Relations joins Proactive London's Katie Pilbeam about their partner AMC Holdings placing its first order a little over a month after signing a supply deal worth up to US$24mln over the next three years.

He explains how the US$3mln purchase order is for CimetrA, MGC’s curcumin and Boswellia compound, giving them exposure to three markets, 'we have three opportunities', he says. 

At 110,000 units of CimetrA, this is the biggest single order the company has received for the product to date.

MGC Pharmaceuticals reveals strategic objectives for H1 2024

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) CEO and Managing Director Roby Zomer speaks to Thomas Warner from Proactive London following the completion of a share consolidation and capital raise. With these restructuring initiatives completed, Zomer shares his enthusiasm for the...

on 11/13/2023